Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1.

Journal of medical virology - 1 Feb 2006

Pérez-Alvarez L, Carmona R, Ocampo A, Asorey A, Miralles C, Pérez de Castro S, Pinilla M, Contreras G, Taboada J A, Nájera R

Abstract excerpt

The aim of this study was to investigate the susceptibility to T20 and the dynamics of amino acid changes in HR1 and HR2 of gp41 of HIV-1 obtained from plasma, peripheral blood mononuclear cells (PBMC), and primary isolates (PI) in four highly antiretroviral-experienced patients. These patients received T20 plus an antiretroviral regimen and were followed-up over a period of 40-72 weeks. In one non-responder...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Enfuvirtide

Share to HIV Envelope Protein gp41

Share to HIV Fusion Inhibitors

Share to Peptide Fragments

Share to Proviruses

Share to Salvage Therapy

Source

Identifiers

PMID: 16372284
DOI: 10.1002/jmv.20520

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Long-term monitoring of genotypic and phenotypic resistance to T20 in treated patients infected with HIV-1.PMID 16372284Read ↗

Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20.Semantic proximity Read ↗

Natural resistance-associated mutations to Enfuvirtide (T20) and polymorphisms in the gp41 region of different HIV-1 genetic forms from T20 naive patients.Semantic proximity Read ↗

HIV genetic mutations causing resistance to the new drug T-20: recent findings.Semantic proximity Read ↗

Primary genotypic resistance of HIV-1 to the fusion inhibitor T-20 in long-term infected patients.Semantic proximity Read ↗

Increased polymorphism in the HR-1 gp41 env gene encoding the enfuvirtide (T-20) target in HIV-1 variants harboring multiple antiretroviral drug resistance mutations in the pol gene.Semantic proximity Read ↗

Resistance and replicative capacity of HIV-1 strains selected in vivo by long-term enfuvirtide treatment.Semantic proximity Read ↗

Primary resistance to enfuvirtide (T20) in recently HIV-1 infected, antiretroviral-naive patients from the ANRS Aquitaine Cohort.Semantic proximity Read ↗

Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41.Semantic proximity Read ↗

Uncommon mutations at residue positions critical for enfuvirtide (T-20) resistance in enfuvirtide-naive patients infected with subtype B and non-B HIV-1 strains.Semantic proximity Read ↗

Emergence of a Drug-Dependent Human Immunodeficiency Virus Type 1 Variant during Therapy with the T20 Fusion InhibitorSemantic proximity Read ↗

Mechanism of resistance to S138A substituted enfuvirtide and its application to peptide design.Semantic proximity Read ↗

Determinants of Human Immunodeficiency Virus Type 1 Resistance to Membrane-Anchored gp41-Derived PeptidesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.